Research Title: A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
Principal Investigator: Jay Stallman, M.D.
Description: This is a Phase IIIb, single-masked, 1-year multicenter study of the safety and tolerability of intravitreally administered ranibizumab in subjects with active subfoveal CNV secondary to AMD.
Start Date: November 2005
Project Personnel: Leslie Marcus, CCRC
Location(s): Tucker; 1462 Montreal Road West, Suite 412, Tucker, GA 30084